PATHOLOGY CENTER FOR LYMPHOMA CLINICAL STUDIES

淋巴瘤临床研究资料库中心和病理小组 由专门从事诊断和研究的病理学家领导 淋巴系统的肿瘤疾病，并正在共同努力 改进和完善诊断和分类的标准 这些肿瘤疾病，从而保证了治疗的有效性 他们的临床同事从事治疗的结果 临床研究。病理小组和资料库中心 淋巴瘤临床研究有五个主要目标，它们是密切相关的 相互关联：(1)维护病理资料库中心和 由美国国立卫生研究院资助的地区淋巴瘤临床研究中心 合作小组和供临床研究的病理学参考文件 霍奇金氏病；(2)重复性和临床相关性检验 临床用非霍奇金淋巴瘤新剂型的研究 国际专家小组推荐；(3)病理学家教育 谁负责合作方案研究的进入诊断 以努力提高他们的诊断质量，从而 最大限度地减少任何患者加入他们不属于的方案； (4)为从事临床合作研究的团体提供研究支持 淋巴瘤临床研究；(5)利用组织病理学资料 存储在存储库中心，用于密切合作研究项目 与首要目标相关。此外，病理小组正在寻求 将其他辅助方法纳入多学科方法，以 恶性淋巴瘤的诊断和分类。

The Repository Center and the Pathology Panel for Lymphoma Clinical Studies are headed by pathologists who have specialized in the diagnosis and study of neoplastic diseases of the lymphoid system and are making a joint effort to improve and refine the criteria for diagnosis and classification of these neoplastic diseases, thus assuring the validity of the therapeutic results obtained by their clinical colleagues engaged in therapeutic clinical studies. The Pathology Panel and the Repository Center for Lymphoma Clinical Studies have five major objectives which are closely interrelated: (1) Maintenance of a Pathology Repository Center and Regional Centers for lymphoma clinical studies conducted by NIH supported cooperative groups and of a pathology reference file for clinical study of Hodgkin's disease; (2) Testing the Reproducibility and clinical relevance of the New Working Formulation of non-Hodgkin's lymphoma for clinical usage recommended by an expert international panel; (3) Education of pathologists who are responsible for entry diagnoses of the cooperative protocol studies in an effort to increase the quality of their diagnoses and thereby minimize entry of any patients into protocols to which they do not belong; (4) Furnishing research support for clinical cooperative groups engaged in lymphoma clinical studies; (5) Utilizing the histopathologic material stored in the Repository Center for collaborative research projects closely related to the primary aim. In addition, the Pathology Panel is seeking to incorporate other ancillary methods into a multidisciplinary approach for the diagnosis and classification of malignant lymphomas.